Table 2

Conditional 5-year relative survival estimates, by type of cancer, disease stage and number of years since diagnosis, for patients aged 15–89 years at diagnosis, NSW Australia 1998-2006
Type of cancer Number of patients Estimated conditional 5-year relativesurvival
At diagnosis 1 year after diagnosis 3 years after diagnosis 5 years after diagnosis 10 years after diagnosis
Localised
Stomach 1247 54.4 75.0 90.3 94.7 93.8
Colorectum 11450 89.6 93.3 95.1 97.4 99.0
Pancreas 849 9.9 24.7 65.1 76.5 98.5
Lung 5202 32.9 51.2 73.2 80.0 82.4
Melanoma† 20077 99.2 98.9 98.7 99.1 99.3
Breast (females) 19468 97.2 96.6 95.8 95.8 95.4
Cervix 1157 86.3 88.9 94.5 96.9 96.2
Prostate 18308 97.9 97.1 96.0 94.2 90.6
Kidney 3734 87.8 89.8 91.3 90.9 90.1
Bladder 3111 72.7 79.1 85.5 88.6 92.0
Thyroid 2920 99.7 100.0 99.5 99.4 99.2
Regional
Stomach 1881 28.7 41.9 68.2 85.9 97.7
Colorectum 14965 67.2 71.5 82.0 90.1 98.5
Pancreas 965 8.2 19.3 61.3 84.2 95.9
Lung 4270 18.7 32.3 58.3 68.6 81.7
Melanoma† 4563 73.8 73.4 81.2 86.9 99.3
Breast (females) 12552 83.7 81.5 83.3 84.8 89.2
Cervix 616 59.7 67.5 80.8 89.0 92.4
Prostate 2237 87.8 88.3 89.0 88.3 81.7
Kidney 1202 54.7 65.3 81.3 89.4 82.8
Bladder 965 36.4 51.0 75.2 86.0 95.1
Thyroid 863 92.6 96.2 96.1 94.7 96.1
Distant
Stomach 1289 5.2 20.6 81.2 93.4 95.5
Colorectum 5576 11.9 23.9 56.4 83.4 93.9
Pancreas 2059 2.3 20.4 62.4 83.2 98.7
Lung 8000 2.8 14.4 59.2 83.5 98.7
Melanoma† 1222 32.3 54.6 79.3 84.1 91.2
Breast (females) 1769 39.4 48.6 59.8 67.6 82.5
Cervix 149 18.4 40.0 71.2 76.3 93.6
Prostate 1577 16.8 25.9 43.4 53.6 80.7
Kidney 1031 6.4 20.3 59.1 65.9 76.7
Bladder 376 4.6 17.3 52.5 92.6 73.6
Thyroid 161 50.0 70.9 79.7 85.9 91.1
Unknown
Stomach 776 27.7 53.9 81.7 88.8 85.3
Colorectum 3464 64.5 77.8 87.9 92.1 96.8
Pancreas 1340 6.9 23.3 67.7 81.3 77.5
Lung 5555 10.9 21.9 54.8 71.2 84.9
Melanoma† 2026 94.4 93.6 94.2 95.1 99.0
Breast (females) 2796 78.5 81.0 86.6 90.4 93.9
Cervix 446 74.9 83.4 90.6 95.7 92.2
Prostate 17729 90.0 88.7 88.6 86.9 89.4
Kidney 973 51.5 66.8 79.6 85.7 88.7
Bladder 1702 69.8 79.7 89.5 92.5 88.2
Thyroid 564 94.2 98.6 99.4 99.9 96.5

† Thickness of the lesion was also used to categorise disease stage at diagnosis for melanoma [T3 (thickness = 2.01-4.0 mm) and T4 (thickness > 4.0 mm) stages were grouped with ‘spread to regional lymph nodes’ as ”regional”]. Since thickness data prior to 1983 were considered unreliable, we used melanoma data from 1983 onward for the stage-specific survival estimates.

Yu et al.

Yu et al. BMC Cancer 2012 12:460   doi:10.1186/1471-2407-12-460

Open Data